514 related articles for article (PubMed ID: 32629115)
1. A pharmacological perspective of chloroquine in SARS-CoV-2 infection: An old drug for the fight against a new coronavirus?
Oscanoa TJ; Romero-Ortuno R; Carvajal A; Savarino A
Int J Antimicrob Agents; 2020 Sep; 56(3):106078. PubMed ID: 32629115
[TBL] [Abstract][Full Text] [Related]
2. Advances in the use of chloroquine and hydroxychloroquine for the treatment of COVID-19.
Sun J; Chen Y; Fan X; Wang X; Han Q; Liu Z
Postgrad Med; 2020 Sep; 132(7):604-613. PubMed ID: 32496926
[TBL] [Abstract][Full Text] [Related]
3. Chloroquine and hydroxychloroquine in coronavirus disease 2019 (COVID-19). Facts, fiction and the hype: a critical appraisal.
Khuroo MS
Int J Antimicrob Agents; 2020 Sep; 56(3):106101. PubMed ID: 32687949
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Pandemic - A Narrative Review of the Potential Roles of Chloroquine and Hydroxychloroquine.
de Barros CM; Almeida CAF; Pereira B; Costa KCM; Pinheiro FA; Maia LDB; Trindade CM; Garcia RCT; Torres LH; Diwan S; Boralli VB
Pain Physician; 2020 Aug; 23(4S):S351-S366. PubMed ID: 32942793
[TBL] [Abstract][Full Text] [Related]
5. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.
Tripathy S; Dassarma B; Roy S; Chabalala H; Matsabisa MG
Int J Antimicrob Agents; 2020 Aug; 56(2):106028. PubMed ID: 32450198
[TBL] [Abstract][Full Text] [Related]
6. Current pharmacological modalities for management of novel coronavirus disease 2019 (COVID-19) and the rationale for their utilization: A review.
Giovane RA; Rezai S; Cleland E; Henderson CE
Rev Med Virol; 2020 Sep; 30(5):e2136. PubMed ID: 32644275
[TBL] [Abstract][Full Text] [Related]
7. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
8. The possible mechanisms of action of 4-aminoquinolines (chloroquine/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): A role for iron homeostasis?
Quiros Roldan E; Biasiotto G; Magro P; Zanella I
Pharmacol Res; 2020 Aug; 158():104904. PubMed ID: 32430286
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review.
Hashem AM; Alghamdi BS; Algaissi AA; Alshehri FS; Bukhari A; Alfaleh MA; Memish ZA
Travel Med Infect Dis; 2020; 35():101735. PubMed ID: 32387694
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antiviral effect of hydroxychloroquine and azithromycin in combination against SARS-CoV-2: What molecular dynamics studies of virus-host interactions reveal.
Fantini J; Chahinian H; Yahi N
Int J Antimicrob Agents; 2020 Aug; 56(2):106020. PubMed ID: 32405156
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).
Shah S; Das S; Jain A; Misra DP; Negi VS
Int J Rheum Dis; 2020 May; 23(5):613-619. PubMed ID: 32281213
[TBL] [Abstract][Full Text] [Related]
12. Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: a systematic review.
Rodrigo C; Fernando SD; Rajapakse S
Clin Microbiol Infect; 2020 Aug; 26(8):979-987. PubMed ID: 32470568
[TBL] [Abstract][Full Text] [Related]
13. Beyond Anti-viral Effects of Chloroquine/Hydroxychloroquine.
Gies V; Bekaddour N; Dieudonné Y; Guffroy A; Frenger Q; Gros F; Rodero MP; Herbeuval JP; Korganow AS
Front Immunol; 2020; 11():1409. PubMed ID: 32714335
[TBL] [Abstract][Full Text] [Related]
14. Impact of Hydroxychloroquine/Chloroquine in COVID-19 Therapy: Two Sides of the Coin.
Fatima U; Rizvi SSA; Fatima S; Hassan MI
J Interferon Cytokine Res; 2020 Oct; 40(10):469-471. PubMed ID: 32881593
[TBL] [Abstract][Full Text] [Related]
15. Overview of lethal human coronaviruses.
Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W
Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062
[TBL] [Abstract][Full Text] [Related]
16. Chloroquine and Hydroxychloroquine in COVID-19: Practice Implications for Healthcare Professionals.
Mallhi TH; Ahmad A; Butt MH; Misbah S; Khan YH; Alotaibi NH
J Coll Physicians Surg Pak; 2020 Oct; 30(10):124-128. PubMed ID: 33115586
[TBL] [Abstract][Full Text] [Related]
17. Elucidating the Pivotal Immunomodulatory and Anti-Inflammatory Potentials of Chloroquine and Hydroxychloroquine.
Richard SA; Kampo S; Hechavarria ME; Sackey M; Buunaaim ADB; Kuugbee ED; Anabah TW
J Immunol Res; 2020; 2020():4582612. PubMed ID: 33062720
[TBL] [Abstract][Full Text] [Related]
18. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C
Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561
[TBL] [Abstract][Full Text] [Related]
19. Janus sword actions of chloroquine and hydroxychloroquine against COVID-19.
Chen X; Geiger JD
Cell Signal; 2020 Sep; 73():109706. PubMed ID: 32629149
[TBL] [Abstract][Full Text] [Related]
20. Effect of chloroquine and hydroxychloroquine on COVID-19 virological outcomes: An updated meta-analysis.
Das RR; Behera B; Mishra B; Naik SS
Indian J Med Microbiol; 2020; 38(3 & 4):265-272. PubMed ID: 33154234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]